Opaleye Management’s Outset Medical OM Stock Holding History

Opaleye Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,000	Closed	-$2.25M	–	63
2020 Q3	$2.25M	Buy	+3,000	New	+$2.46M	0.44%	44

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Opaleye Management's OM Position: Q4 2020 in Review

Opaleye Management sold out of Outset Medical (OM) in Q4 2020, closing a stake of 3,000 shares — an estimated $2.25M sold.

Opaleye Management first reported a position in OM in Q3 2020 and held it in 1 quarter. The position peaked at $2.25M in Q3 2020. 111 funds tracked by Wall St. Rank hold OM as of Q4 2020.

Opaleye Management reported no remaining Outset Medical position as of Q4 2020 after selling out during the quarter.
Opaleye Management sold 3,000 Outset Medical shares in Q4 2020, an estimated $2.25M.
Opaleye Management first reported a position in Outset Medical in Q3 2020 and held it in 1 quarter.
Opaleye Management's Outset Medical position peaked at $2.25M in Q3 2020.
111 funds tracked by Wall St. Rank held Outset Medical as of Q4 2020.

Based on Opaleye Management's 13F filing for Q4 2020, filed 12 Feb 2021.